Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
NCT04821375
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Increased Risk for Development of Breast Cancer
Interventions
DRUG:
bazedoxifene plus conjugated estrogens
Sponsor
Carol Fabian, MD